Email Alert RSS
Volume 11 Issue 3
May  2020
Turn off MathJax
Article Contents
Article Navigation >  Medical Journal of Peking Union Medical College Hospital  > 2020  >  11(3): 296-300
Huai-ya XIE, Chao LI, Yu-bing WEN, Wei YE, Jian-fang CAI, Hang LI, Xue-mei LI, Xue-wang LI. Efficacy and Prognosis of Calcineurin inhibitors and Cyclophosphamide in Treating Idiopathic Membranous Nephropathy in Patients with Type 2 Diabetes[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(3): 296-300. doi: 10.3969/j.issn.1674-9081.20180463
Citation: Huai-ya XIE, Chao LI, Yu-bing WEN, Wei YE, Jian-fang CAI, Hang LI, Xue-mei LI, Xue-wang LI. Efficacy and Prognosis of Calcineurin inhibitors and Cyclophosphamide in Treating Idiopathic Membranous Nephropathy in Patients with Type 2 Diabetes[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(3): 296-300. doi: 10.3969/j.issn.1674-9081.20180463
shu

Efficacy and Prognosis of Calcineurin inhibitors and Cyclophosphamide in Treating Idiopathic Membranous Nephropathy in Patients with Type 2 Diabetes

doi: 10.3969/j.issn.1674-9081.20180463
  • 1.

    Department of Internal Medicine,Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

  • 2.

    Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

More Information
  • Corresponding author: CAI Jian-fang Tel:86-10-69155058,E-mail:caijfbj@126.com
  • Received Date: 2018-12-20
  • Publish Date: 2020-05-30
    Abstract
  •   Objective  The aim of this study was to compare the efficacy and prognosis of different therapeutic regimens in treating idiopathic membranous nephropathy (IMN) in patients with type 2 diabetes.  Methods  The clinical data were retrospectively collected and analyzed in patients with IMN and type 2 diabetes admitted in the Peking Union Medical College Hospital from January 2004 to April 2015. The patients were classified into three groups and designated as cyclophosphamide (CTX), calcineurin inhibitors (CNIs)and other immunosuppressants groups according to the initial therapeutic regimens. Kaplan-Meier analysis and multivariable Cox regression were used to assess the influence of therapeutic regimens on total remission (TR), complete remission (CR), risks of developing ≥ 30% decline in estimated glomerular filtration rate (eGFR) or end-stage renal disease (ESRD), and risks of achieving fast blood glucose >8 mmol/L.  Results  Totally, 89 patients meeting the inclusive and exclusive criteria were included in this study. The multivariable Cox analysis showed that patients initially treated with CNIs would be significantly higher to develop ≥ 30% eGFR decline or ESRD (HR=13.505, 95% CI:1.512-120.665, P=0.020) than those treated with CTX. However, the likeliness to reach CR(HR=0.793, 95% CI:0.315-1.999, P=0.623), TR(HR=0.647, 95% CI:0.334-1.252, P=0.196), or fast blood glucose >8 mmol/L (HR=1.709, 95% CI:0.669-4.369, P=0.263) were similar between the two groups.  Conclusions  In patients with type 2 diabetes, CNIs as the initial treatment for IMN might have comparable remission rate of proteinuria with CTX, but an extra risk of renal function decline. We would better be cautious in choosing the therapeutic regimens to treat IMN in patients with type 2 diabetes.
    • FullText(HTML)
  • loading
    • References(12)
  • [1] 中国医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中国糖尿病杂志, 2018, 10:4-67.
    [2] Grujicic M, Salapura A, Basta-Jovanovic G, et al. Non-diabetic kidney disease in patients with type 2 diabetes mellitus-11-year experience from a single center[J]. Med Arch, 2019, 73:87-91. doi:  10.5455/medarh.2019.73.87-91
    [3] Horvatic I, Tisljar M, Kacinari P, et al. Non-diabetic renal disease in Croatian patients with type 2 diabetes mellitus[J]. Diabetes Res Clin Pract, 2014, 104:443-450. doi:  10.1016/j.diabres.2014.03.016
    [4] Chapter 7:Idiopathic membranous nephropathy[J]. Kidney Int Suppl(2011), 2012, 2:186-197.
    [5] Chen Y, Schieppati A, Chen X, et al. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome[J]. Cochrane Databases Syst Rev, 2014, (10):CD004293. https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0012676/
    [6] American Diabetes Association. Standards of medical care in diabetes——2011[J]. Diabetes Care, 2011, 34 Suppl 1:S11-S61. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=PubMed000002346022
    [7] 邹万忠. 肾活检病理诊断指导意见[J]. 中国肾脏病杂志, 2001, 17:270-275.
    [8] Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate[J]. Ann Intern Med, 2009, 150:604-612. doi:  10.7326/0003-4819-150-9-200905050-00006
    [9] Chapter 2:General principles in the management of glomerular disease[J]. Kidney Int Suppl(2011), 2012, 2:156-162.
    [10] Qiu TT, Zhang C, Zhao HW, et al. Calcineurin inhibitors versus cyclophosphamide for idiopathic membranous nephropathy:A systematic review and meta-analysis of 21 clinical trials[J]. Autoimmun Rev, 2017, 16:136-145. doi:  10.1016/j.autrev.2016.12.005
    [11] Howman A, Chapman TL, Langdon MM, et al. Immunosuppression for progressive membranous nephropathy:a UK randomised controlled trial[J]. Lancet, 2013, 381:744-751. doi:  10.1016/S0140-6736(12)61566-9
    [12] Coresh J, Turin TC, Matsushita K, et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality[J]. JAMA, 2014, 311:2518-2531. doi:  10.1001/jama.2014.6634
    • Relative Articles(0)
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(2)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (412) PDF downloads(217) Cited by()
    Proportional views
    Related
    Links: National Health Commission of the People's Republic of China Chinese Academy of Medical Sciences(CAMS) AMLC Check CNKI Database CNKI Term Online Chinese General Practice
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn
    mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return